Clinical Trials Browser

Phase 1 × Adenocarcinoma × zolbetuximab × Clear all

NCT04086758 2024-11-20

A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Phase 1 Completed

Adenocarcinoma